ImmuDyne Signs Exclusive License Agreement for Clinically-Backed Solar Purpura Product
Mar 28, 2018 12:00 pm UTC| Business
NEW YORK, March 28, 2018 -- ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of Over-the-Counter healthcare products, is pleased to announce the signing of an...
Terrestrial Energy USA Signs MOU with Energy Northwest for Idaho National Laboratory Project
Mar 28, 2018 12:00 pm UTC| Business
NEW YORK, March 28, 2018 -- Terrestrial Energy USA and Energy Northwest have announced today that they have reached a Memorandum of Understanding (MOU) on the terms of the possible siting, construction and operation of...
Mar 28, 2018 12:00 pm UTC| Business
ANAHEIM, Calif., March 28, 2018 -- Tone Software Corporation, a global provider of comprehensive management and productivity solutions for IBM z/OS mainframe environments, today announced immediate availability of the...
Paratek Pharmaceuticals to Present at the H.C. Wainwright Annual Global Life Sciences Conference
Mar 28, 2018 12:00 pm UTC| Business
BOSTON, March 28, 2018 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that President, Chief Operating Officer and Chief Medical Officer, Evan Loh, MD will present at the upcoming H.C. Wainwright Annual...
Umpqua Holdings Corporation Announces First Quarter 2018 Earnings Conference Call on April 19, 2018
Mar 28, 2018 12:00 pm UTC| Business
PORTLAND, Ore., March 28, 2018 -- Umpqua Holdings Corporation (NASDAQ:UMPQ), parent company of Umpqua Bank and Umpqua Investments, today announced that it will host its first quarter 2018 earnings conference call on...
Award-Winning Venues with OpenAire Retractable Roofs
Mar 28, 2018 12:00 pm UTC| Business
OAKVILLE, Ontario, March 28, 2018 -- OpenAire has been committed to creating remarkable design solutions for clients around the world for nearly 30 years. Since 1989, our team of architects, designers, and engineers has...
Albireo to Present Clinical Data on A4250 at The International Liver Congress™ 2018
Mar 28, 2018 12:00 pm UTC| Business
BOSTON, March 28, 2018 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that new data from its completed Phase 2 trial...
China Signals Subtle Treasury Pullback: Banks Urged to Ease US Debt Exposure
China Signals Quiet Treasury Trim: Banks Told to Ease Up on US Debt
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma